Cited by 783Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsHereditary Neurological Disorders

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Open access

Haidet-Phillips, Amanda M, Hester, Mark E, Miranda, Carlos J, Meyer, Kathrin, Braun, Lyndsey, Frakes, Ashley, Song, SungWon, Likhite, Shibi, Murtha, Matthew J, Foust, Kevin D, Rao, Meghan, Eagle, Amy, Kammesheidt, Anja, Christensen, Ashley, Mendell, Jerry R, Burghes, Arthur H M, Kaspar, Brian K·2011·Nature Biotechnology

DOI 10.1038/nbt.1957PMC PMC3170425

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, with astrocytes implicated as contributing substantially to motor neuron death in familial (F)ALS. However, the proposed role of astrocytes in the pathology of ALS derives in part from rodent models of FALS based upon dominant mutations within the superoxide dismutase 1 (SOD1) gene, which account for <2% of all ALS cases. Their role in sporadic (S)ALS, which affects >90% of ALS patients, remains to be established. Using astrocytes generated from postmortem tissue from both FALS and SALS patients, we show that astrocytes derived from both patient groups are similarly toxic to motor neurons. We also demonstrate that SOD1 is a viable target for SALS, as its knockdown significantly attenuates astrocyte-mediated toxicity toward motor neurons. Our data highlight astrocytes as a non-cell autonomous component in SALS and provide an in vitro model system to investigate common disease mechanisms and evaluate potential therapies for SALS and FALS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.1957

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 2,019
Directed differentiation of embryonic stem cells into motor neurons.
Wichterle, H., Lieberam, I., Porter, J. A., & Jessell, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00835-8 · Cited by 1,792
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 1×
“Recently, novel vectors have been shown to efficiently target astrocytes of adult brain and spinal cor”
BackgroundSelf-citation
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W. T., Siwek, D. F., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,131

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 201–300 of 783

A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis‐linked SOD1 mutants
Fujisawa, T., Homma, K., Yamaguchi, N., Kadowaki, H., Tsuburaya, N., Naguro, I., Matsuzawa, A., Takeda, K., Takahashi, Y., Goto, J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23668 · Cited by 81
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
Pandya, R. S., Zhu, H., Li, W., Bowser, R. P., Friedlander, R. M., & Wang, X. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1415-0 · Cited by 77
Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS
Wang, T., Perera, N. D., Chiam, M. D. F., Cuic, B., Wanniarachchillage, N., Tomas, D., Samson, A. L., Cawthorne, W., Valor, E. N., Murphy, J. M., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0457-8 · Cited by 76
Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 80
A stocked toolbox for understanding the role of astrocytes in disease
Almad, A., & Maragakis, N. J. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0010-2 · Cited by 80
Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction
Peng, A. Y. T., Agrawal, I., Ho, W. Y., Yen, Y.-C., Pinter, A. J., Liu, J., Phua, Q. X. C., Koh, K. B., Chang, J., Sanford, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007806117 · Cited by 77
Neurosphere Based Differentiation of Human iPSC Improves Astrocyte Differentiation
Zhou, S., Szczęsna, K., Ochałek, A., Kobolák, J., Varga, E., Nemes, C., Chandrasekaran, A., Rasmussen, M. A., Cirera, S., Hyttel, P., et al. (2015) · Stem Cells International · doi:10.1155/2016/4937689 · Cited by 82
Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration
Yaron, A., & Schuldiner, O. (2016) · Current Biology · doi:10.1016/j.cub.2016.05.025 · Cited by 81
Autophagy in Astrocytes and its Implications in Neurodegeneration
Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 78
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 76
Mechanisms Involved in Spinal Cord Central Synapse Loss in a Mouse Model of Spinal Muscular Atrophy
Tarabal, O., Caraballo-Miralles, V., Cardona-Rossinyol, A., Correa, F. J., Olmos, G., Lladó, J., Esquerda, J. E., & Calderó, J. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000074 · Cited by 75
Accessory respiratory muscles enhance ventilation in ALS model mice and are activated by excitatory V2a neurons
Romer, S. H., Seedle, K., Turner, S. M., Li, J., Baccei, M. L., & Crone, S. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.033 · Cited by 71
Astrocytes and synaptic plasticity in health and disease
Singh, A., & Abraham, W. C. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-4928-1 · Cited by 78
Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy
Do‐Ha, D., Buskila, Y., & Ooi, L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0392-y · Cited by 81
Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models
Izrael, M., Slutsky, S. G., Admoni, T., Cohen, L., Granit, A., Hasson, A., Itskovitz‐Eldor, J., Paker, L. K., Kuperstein, G., Lavon, N., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0890-5 · Cited by 74
Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP‐43 ( A315T ) transgenic mice, a model of amyotrophic lateral sclerosis
Espejo‐Porras, F., García‐Toscano, L., Rodríguez‐Cueto, C., Santos‐García, I., de Lago, E., & Fernández‐Ruíz, J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14216 · Cited by 74
Neurotropism of Enterovirus D68 Isolates Is Independent of Sialic Acid and Is Not a Recently Acquired Phenotype
Rosenfeld, A. B., Warren, A. L., & Racaniello, V. R. (2019) · mBio · doi:10.1128/mbio.02370-19 · Cited by 73
Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease
Izrael, M., Slutsky, S. G., & Revel, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00824 · Cited by 73
Stem Cells of the Aging Brain
Nicaise, A. M., Willis, C. M., Crocker, S. J., & Pluchino, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00247 · Cited by 76
The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity
Provenzano, F., Torazza, C., Bonifacino, T., Bonanno, G., & Milanese, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015430 · Cited by 78
Human-derived neural progenitors functionally replace astrocytes in adult mice
Chen, H., Qian, K. X., Chen, W., Hu, B., Blackbourn, L., Du, Z., Ma, L., Liu, H., Knobel, K. M., Ayala, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci69097 · Cited by 72
Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models
Harlan, B. A., Killoy, K. M., Pehar, M., Liu, L., Auwerx, J. H., & Vargas, M. R. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113219 · Cited by 71
More Than Mortar: Glia as Architects of Nervous System Development and Disease
Lago‐Baldaia, I., Fernandes, V. M., & Ackerman, S. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611269 · Cited by 74
FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms
Dittlau, K. S., Terrie, L., Baatsen, P., Kerstens, A., Swert, L. D., Janky, R., Corthout, N., Masrori, P., Damme, P. V., Hyttel, P., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00591-3 · Cited by 69
Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P‐Glycoprotein) in endothelial cells of the blood–brain barrier in mutant superoxide dismutase 1‐linked amyotrophic lateral sclerosis
Qosa, H., Lichter, J., Sarlo, M., Markandaiah, S. S., McAvoy, K., Richard, J., Jablonski, M., Maragakis, N. J., Pasinelli, P., & Trotti, D. (2016) · Glia · doi:10.1002/glia.23003 · Cited by 70
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS
Vijayakumar, U. G., Milla, V., Stafford, M. Y. C., Bjourson, A. J., Duddy, W. J., & Duguez, S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00400 · Cited by 71
The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response
Lee, S., Kim, S., Kang, H., Lim, H. R., Kwon, Y., Jo, M., Jeon, Y.-M., Kim, K., Kim, K., Ha, C. M., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01963-6 · Cited by 73
Prion-like activity of Cu/Zn superoxide dismutase
Grad, L. I., & Cashman, N. R. (2014) · Prion · doi:10.4161/pri.27602 · Cited by 69
Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis
Ditsworth, D., Maldonado, M., McAlonis‐Downes, M., Sun, S., Seelman, A., Drenner, K., Arnold, E. S., Ling, S., Pizzo, D. P., Ravits, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1698-6 · Cited by 72
The Gypsy Endogenous Retrovirus Drives Non-Cell-Autonomous Propagation in a Drosophila TDP-43 Model of Neurodegeneration
Chang, Y.-H., & Dubnau, J. (2019) · Current Biology · doi:10.1016/j.cub.2019.07.071 · Cited by 68
Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS
Almad, A. A., Taga, A., Joseph, J., Gross, S. K., Welsh, C., Patankar, A. G., Richard, J., Rust, K., Pokharel, A., Plott, C. F., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107391119 · Cited by 68
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Tsekrekou, M., Giannakou, M., Papanikolopoulou, K., & Σκρέτας, Γ. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1383453 · Cited by 71
The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis
Nonneman, A., Robberecht, W., & Bosch, L. V. D. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.21 · Cited by 76
FABP7 upregulation induces a neurotoxic phenotype in astrocytes
Killoy, K. M., Harlan, B. A., Pehar, M., & Vargas, M. R. (2020) · Glia · doi:10.1002/glia.23879 · Cited by 64
Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research
Engel, M., Do‐Ha, D., Muñoz, S. S., & Ooi, L. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2265-3 · Cited by 69
An update on human astrocytes and their role in development and disease
de Majo, M., Koontz, M., Rowitch, D. H., & Ullian, E. M. (2020) · Glia · doi:10.1002/glia.23771 · Cited by 69
Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids
Tamaki, Y., Ross, J. P., Alipour, P., Castonguay, C.-E., Li, B., Catoire, H., Rochefort, D. L., Urushitani, M., Takahashi, R., Sonnen, J. A., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010606 · Cited by 67
Epigenetic changes in the developing brain: Effects on behavior
Keverne, E. B., Pfaff, D. W., & Tabansky, I. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501482112 · Cited by 68
Body mass index and dietary intervention: Implications for prognosis of amyotrophic lateral sclerosis
Ngo, S. T., Steyn, F. J., & McCombe, P. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.02.035 · Cited by 70
Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells
Xu, X., & Zhong, Z. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.63 · Cited by 67
Screening the expression characteristics of several miRNAs in G93A‐SOD1 transgenic mouse: altered expression of miRNA‐124 is associated with astrocyte differentiation by targeting Sox2 and Sox9
Zhou, F., Zhang, C., Guan, Y., Chen, Y., Lü, Q., Jie, L., Gao, H., Du, H., Zhang, H., Liu, Y., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14229 · Cited by 64
Induced pluripotent stem cells from ALS patients for disease modeling
Richard, J., & Maragakis, N. J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.017 · Cited by 71
Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment
Calió, M. L., Henriques, E., Siena, A., Bertoncini, C. R. A., Gil-Mohapel, J., & Rosenstock, T. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00679 · Cited by 64
Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning
Kumar, V., Islam, A., Hassan, M. I., & Ahmad, F. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.017 · Cited by 69
Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis
Rodríguez‐Cueto, C., Santos‐García, I., García‐Toscano, L., Espejo‐Porras, F., Bellido, M., Fernández‐Ruíz, J., Muñóz, E., & de Lago, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.049 · Cited by 66
R13 preserves motor performance in SOD1 G93A mice by improving mitochondrial function
Li, X., Chen, C., Xu, Z., Li, B., Zhang, Z., Li, S., Xie, Y., Song, X., Shen, Y., Liu, J., et al. (2021) · Theranostics · doi:10.7150/thno.56070 · Cited by 64
Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications
Steinruecke, M., Lonergan, R. M., Selvaraj, B. T., Chandran, S., Castro, B. D., & Stavrou, M. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231153281 · Cited by 63
Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients
Mishra, P. S., Dhull, D. K., Nalini, A., Vijayalakshmi, K., Sathyaprabha, T. N., Alladi, P. A., & Raju, T. R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0698-0 · Cited by 63
Regionally specified human pluripotent stem cell-derived astrocytes exhibit different molecular signatures and functional properties
Bradley, R. A., Shireman, J. M., McFalls, C., Choi, J., Canfield, S. G., Dong, Y. W., Liu, K. A., Lisota, B., Jones, J. R., Petersen, A. J., et al. (2019) · Development · doi:10.1242/dev.170910 · Cited by 65
TIMP-1: A key cytokine released from activated astrocytes protects neurons and ameliorates cognitive behaviours in a rodent model of Alzheimer’s disease
Saha, P., Sarkar, S., Paidi, R. K., & Biswas, S. C. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.014 · Cited by 63
The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review
Cecerska‐Heryć, E., Pękała, M., Serwin, N. M., Gliźniewicz, M., Grygorcewicz, B., Michalczyk, A., Heryć, R., Budkowska, M., & Dołęgowska, B. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01344-6 · Cited by 71
Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis
Lewis, C. M., & Suzuki, M. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt421 · Cited by 65
Astrocyte–neuron co-culture on microchips based on the model of SOD mutation to mimic ALS
Kunze, A., Lengacher, S., Dirren, E., Aebischer, P., Magistretti, P. J., & Renaud, P. (2013) · Integrative Biology · doi:10.1039/c3ib40022k · Cited by 62
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model
Cui, Y., Masaki, K., Yamasaki, R., Imamura, S., Suzuki, S. O., Hayashi, S., Sato, S., Nagara, Y., Kawamura, M. F., & Kira, J. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-42 · Cited by 61
EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis
Rosenblum, L. T., & Trotti, D. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-55769-4_6 · Cited by 66
From nucleation to widespread propagation: A prion-like concept for ALS
Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65
G protein-coupled receptor signalling in astrocytes in health and disease: A focus on metabotropic glutamate receptors
Bradley, S. J., & Challiss, R. A. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.009 · Cited by 66
Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Liberman, A. C., Trías, E., Chagas, L. D. S., Trindade, P., Pereira, M. D. S., Refojo, D., Hedin‐Pereira, C., & Serfaty, C. A. (2018) · NeuroImmunoModulation · doi:10.1159/000494761 · Cited by 62
Blocking immune cell infiltration of the central nervous system to tame Neuroinflammation in Amyotrophic lateral sclerosis
Garofalo, S., Cocozza, G., Bernardini, G., Savage, J. C., Raspa, M., Aronica, E., Tremblay, M., Ransohoff, R. M., Santoni, A., & Limatola, C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.004 · Cited by 59
Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease.
Gatto, N., Dos Santos Souza, C., Shaw, A. C., Bell, S. M., Myszczynska, M. A., Powers, S., Meyer, K., Castelli, L. M., Karyka, E., Mortiboys, H., et al. (2021) · Aging Cell · doi:10.1111/acel.13281 · Cited by 58
Self-citation
Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm
Song, Y., Nagy, M., Ni, W., Tyagi, N. K., Fenton, W. A., López‐Giráldez, F., Overton, J. D., Horwich, A. L., & Brady, S. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303279110 · Cited by 59
AAV9-mediated central nervous system–targeted gene delivery via cisterna magna route in mice
Lukashchuk, V., Lewis, K. E. A., Coldicott, I., Grierson, A. J., & Azzouz, M. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2015.55 · Cited by 60
Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors
Artero‐Castro, A., Rodríguez-Jiménez, F. J., Jendelová, P., VanderWall, K. B., Meyer, J. S., & Erceg, S. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101817 · Cited by 60
p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Fujita, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236023 · Cited by 59
Calcium Ions Promote Superoxide Dismutase 1 (SOD1) Aggregation into Non-fibrillar Amyloid
Leal, S. S., Cardoso, I., Valentine, J. S., & Gomes, C. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470740 · Cited by 60
Proteasome Activation is a Mechanism for Pyrazolone Small Molecules Displaying Therapeutic Potential in Amyotrophic Lateral Sclerosis
Trippier, P. C., Zhao, K. T., Fox, S. G., Schiefer, I. T., Benmohamed, R., Moran, J. M., Kirsch, D. R., Morimoto, R. I., & Silverman, R. B. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500147v · Cited by 57
Using stem cell–derived neurons in drug screening for neurological diseases
Little, D., Ketteler, R., Gissen, P., & Devine, M. J. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.008 · Cited by 56
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111428 · Cited by 59
Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
Lazic, A., Balint, V., Ninković, D. S., Perić, M., & Stevanović, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094995 · Cited by 61
Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Riancho, J., Ruiz‐Soto, M., Berciano, M. T., Berciano, J., & Lafarga, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00250 · Cited by 57
Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS
Trías, E., Díaz‐Amarilla, P., Olivera‐Bravo, S., Isasi, E., Drechsel, D. A., Lopez, N. I., Bradford, C. S., Ireton, K. E., Beckman, J. S., & Barbeito, L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00274 · Cited by 62
Rapid and robust generation of long-term self-renewing human neural stem cells with the ability to generate mature astroglia
Palm, T., Bolognin, S., Meiser, J., Nickels, S., Träger, C., Meilenbrock, R. L., Brockhaus, J., Schreitmüller, M., Missler, M., & Schwamborn, J. C. (2015) · Scientific Reports · doi:10.1038/srep16321 · Cited by 56
A Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood Plasma
Willis, C. M., Ménoret, A., Jellison, E. R., Nicaise, A. M., Vella, A. T., & Crocker, S. J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00335 · Cited by 59
Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery
Soubannier, V., Maussion, G., Chaineau, M., Sigutova, V., Rouleau, G. A., Durcan, T. M., & Stifani, S. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135028 · Cited by 55
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
DeVos, S. L., & Miller, T. M. (2013) · Journal of Visualized Experiments · doi:10.3791/50326-v · Cited by 54
Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons
Barbosa, M., Gomes, C., Sequeira, C., Gonçalves‐Ribeiro, J., Pina, C. C., Carvalho, L. A. R., Moreira, R., Vaz, S. H., Vaz, A. R., & Brites, D. M. T. O. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634355 · Cited by 58
Limited Phenotypic Effects of Selectively Augmenting the SMN Protein in the Neurons of a Mouse Model of Severe Spinal Muscular Atrophy
Lee, A. J. H., Awano, T., Park, G.-H., & Monani, U. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046353 · Cited by 55
¿Por qué degeneran las motoneuronas? Actualización en la patogenia de la esclerosis lateral amiotrófica
Riancho, J., Gonzalo, I., Ruiz‐Soto, M., & Berciano, J. (2016) · Neurología · doi:10.1016/j.nrl.2015.12.001 · Cited by 65
A directional 3D neurite outgrowth model for studying motor axon biology and disease
Spijkers, X. M., Pasteuning-Vuhman, S., Dorleijn, J. C., Vulto, P., Wevers, N. R., & Pasterkamp, R. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-81335-z · Cited by 55
Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities
Soares, P., Silva, C., Chavarria, D., Silva, F. S. G., Oliveira, P. J., & Borges, F. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101790 · Cited by 56
Defects in Motoneuron–Astrocyte Interactions in Spinal Muscular Atrophy
Zhou, C., Feng, Z., & Ko, C. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3534-15.2016 · Cited by 50
The role of glia in protein aggregation
Li, Q., & Haney, M. S. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105015 · Cited by 54
A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress
Thams, S., Lowry, E. R., Larraufie, M.-H., Spiller, K. J., Li, H., Williams, D. J., Hoang, P., Jiang, E., Williams, L. A., Sandoe, J., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.010 · Cited by 51
Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)
Poppe, L., Rué, L., Robberecht, W., & Bosch, L. V. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.001 · Cited by 54
Palmitoylation of Superoxide Dismutase 1 (SOD1) Is Increased for Familial Amyotrophic Lateral Sclerosis-linked SOD1 Mutants
Antinone, S. E., Ghadge, G. D., Lam, T. T., Wang, L., Roos, R. P., & Green, W. N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.487231 · Cited by 51
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
Lu, H., Le, W. D., Xie, Y.-Y., & Wang, X.-P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160120152423 · Cited by 51
Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration
Dutta, K., Patel, P., Rahimian, R., Phaneuf, D., & Julien, J. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0499-2 · Cited by 52
DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis
Larrodé, P., Calvo, A. C., Moreno‐Martínez, L., de la Torre, M., Moreno‐García, L., Molina, N., Castiella, T., Íñiguez, C., Pascual, L. F., Mena, F. J. M., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0713-1 · Cited by 51
Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1
Harlan, B. A., Pehar, M., Killoy, K. M., & Vargas, M. R. (2019) · The FASEB Journal · doi:10.1096/fj.201802752r · Cited by 50
Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow
Mishra, V. R., Ré, D. B., Verche, V. L., Alvarez, M. J., Vasciaveo, A., Jacquier, A., Doulias, P.-T., Greco, T. M., Nizzardo, M., Papadimitriou, D. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19177-y · Cited by 49
An α2-Na/K ATPase/α-adducin complex in astrocytes triggers non–cell autonomous neurodegeneration
Gallardo, G., Barowski, J., Ravits, J., Siddique, T., Lingrel, J. B., Robertson, J., Steen, H., & Bonni, A. (2014) · Nature Neuroscience · doi:10.1038/nn.3853 · Cited by 51
Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS
Iannitti, T., Scarrott, J. M., Likhite, S. B., Coldicott, I., Lewis, K. E. A., Heath, P. R., Higginbottom, A., Myszczynska, M. A., Milo, M., Hautbergue, G. M., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.015 · Cited by 50
Self-citation
Membralin deficiency dysregulates astrocytic glutamate homeostasis, leading to ALS-like impairment
Jiang, L.-L., Zhu, B., Zhao, Y., Li, X., Liu, T., Piña-Crespo, J., Zhou, L., Xu, W., Gómez-Rodríguez, M. J., Yu, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127695 · Cited by 51
Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis
Cao, M. C., Cawston, E. E., Chen, G. L., Brooks, C., Douwes, J. E., McLean, D., Graham, E. S., Dragunow, M., & Scotter, E. L. (2022) · BMC Neurology · doi:10.1186/s12883-022-02730-1 · Cited by 49
Altered astrocytic expression of TDP-43 does not influence motor neuron survival
Haidet-Phillips, A. M., Gross, S. K., Williams, T. L., Tuteja, A., Sherman, A., Ko, M., Jeong, Y. H., Wong, P. C., & Maragakis, N. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.004 · Cited by 51
Self-citation
Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model
Fellner, A., Barhum, Y., Angel, A., Perets, N., Steiner, I., Offen, D., & Lev, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081666 · Cited by 48
Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy
Zheng, W., Li, Q., Zhao, C., Da, Y., Zhang, H., & Chen, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00239 · Cited by 50
Astrocytic Vesicle Mobility in Health and Disease
Potokar, M., Vardjan, N., Stenovec, M., Gabrijel, M., Trkov, S., Jorgačevski, J., Kreft, M., & Zorec, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611238 · Cited by 52
Human Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological Disorders
Tyzack, G. E., Lakatos, A., & Patani, R. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0049-1 · Cited by 49
Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death
Ajmone‐Cat, M. A., Onori, A., Toselli, C., Stronati, E., Morlando, M., Bozzoni, I., Monni, E., Kokaia, Z., Lupo, G., Minghetti, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41040-4 · Cited by 46

Authors: Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., Rao, M., Eagle, A., Kammesheidt, A., Christensen, A., Mendell, J. R., Burghes, A. H. M., & Kaspar, B. K.
Affiliations: Nationwide Children's Hospital (US)
Ambry Genetics (United States) (US)
The Ohio State University (US)
Corresponding author: Kaspar, Brian K
ORCID: Hester, Mark E
Miranda, Carlos J
Meyer, Kathrin
Likhite, Shibi
Foust, Kevin D
Mendell, Jerry R
Burghes, Arthur H M
Kaspar, Brian K
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2011-08-10
Volume: 29
Issue: 9
Pages: 824-828
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.1957
PMC: PMC3170425
OpenAlex: W2059355164
Cited by: 782
References: 30
Citations by year: 2026: 21 · 2025: 29 · 2024: 43 · 2023: 38 · 2022: 54 · 2021: 46 · 2020: 68 · 2019: 59 · 2018: 55 · 2017: 58 · 2016: 66 · 2015: 59 · 2014: 70 · 2013: 59 · 2012: 50
FWCI: 37.69
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Neurological Disorders and Stroke (RC2NS069476, R01 NS644912-1A1, RC2 NS69476-01, R01NS064492, T32NS077984, F31NS058224)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: amyotrophic lateral sclerosis, astrocytes, motor neuron toxicity, sporadic ALS, familial ALS, SOD1, disease mechanisms
MeSH terms: Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Cell Differentiation, Cell Line, Disease Models, Animal, Gene Expression Regulation, Humans, Immunohistochemistry, Motor Neurons, Mutation, Superoxide Dismutase, Signal Transduction, Biomarkers, Sequence Analysis, DNA, Coculture Techniques, Mice, Embryonic Stem Cells, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks